Project Grant HT9425261E309
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $598K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23284, USA
Similar Awards
- Federal Grant Award Summary Virginia Commonwealth University received a $1.84M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to develop and deliver novel cell therapy treatments for advanced prostate cancer. The award, effective September 1, 2025 through August 31, 2028, supports research and development activities designed to translate innovative therapeutic approaches into clinical applications that address critical...
- Federal Grant Award Summary Virginia Commonwealth University received a $1.79M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. The research project, "Targeting Ganglioside GD2 to Overcome Chemotherapy Resistance in Triple-Negative Breast Cancer," focuses on developing innovative therapeutic approaches to address chemotherapy resistance in...
- This federal Project Grant award in the amount of $582,189.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Virginia Commonwealth University (VCU) to investigate the role of histone H2A ubiquitination and the RSF1 gene in breast cancer. The 3-year award, starting on March 1, 2024, will fund personnel, facilities, and equipment to conduct basic, translational, and clinical research aimed at advancing...
- The Department of Defense's Defense Health Agency awarded Virginia Commonwealth University (VCU) a $568,461 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "READING HISTONE H2A UBIQUITINATION IN THE FUNCTION OF RSF1 IN BREAST CANCERS WITH RSF1 GENE AMPLIFICATION." The grant, effective from March 1, 2024 through February 28, 2027, will fund VCU's research to advance the scientific understanding of breast cancer and develop...
- Federal Grant Award Summary The University of Virginia received a $638,260 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 1, 2025, with completion scheduled for August 31, 2027. The award supports research titled "Linking Genetic, Metabolic, and Microenvironmental Predictors of Melanoma Metastatic Colonization," conducted at the university's Charlottesville, Virginia campus. This research...
- Federal Project Grant Award Summary The University of Virginia received an $858,608 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of August 15, 2025 through August 14, 2028. The award supports research into understanding how melanoma-cognate T-cell help enhances survival outcomes in melanoma vaccine interventions. This research initiative contributes to the DHA's broader mission of advancing...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $560,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded July 1, 2026, with completion targeted for June 30, 2028. The award supports fundamental research into the mechanisms of Wnt-driven metastasis, contributing to the DHA's broader mission of transforming healthcare for military service members and the American public through...
- Federal Project Grant Award Summary Virginia Commonwealth University received a $2.58M project grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) awarded September 30, 2025, with a completion date of September 29, 2029. The project, titled "Optimizing Mild Traumatic Brain Injury Diagnostics and Health Care Costs Using a Mathematical Framework and Clinical Decision Support Tool Across the Military," develops mathematical frameworks and...
- Federal Grant Award Summary The University of Virginia received a $5.54 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 30, 2025 through September 29, 2029. The award supports research and development of focused ultrasound interventions designed to provide noninvasive precision therapy approaches for treating primary and metastatic breast cancers. Research activities will be conducted at...
- Federal Project Grant Award Summary George Mason University received a $501,515 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research investigating the role of PIK3CA mutations in tumorigenesis of HER2-positive breast cancer. The award, effective September 1, 2026, through August 31, 2029, funds hypothesis-driven biomedical research designed to advance medical solutions and transform healthcare for service...